Midatech Pharma plc (MTP) Research

Midatech Pharma plc is a pharmaceutical company focused on the research and development of drug delivery technologies and therapeutic solutions across the United Kingdom, Europe, and international markets. Its active pipeline includes MTX110, an investigational direct-delivery treatment for aggressive brain tumors such as diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme. Also in development are MTX114, a topical immunosuppressant for managing psoriasis; MTD211, an extended-release formulation of brexpiprazole for schizophrenia and as an adjunct for major depressive disorder; and MTD219, a long-acting version of tacrolimus designed to mitigate the risk of organ transplant rejection. The company also leverages proprietary drug delivery platforms: Q-Sphera, a polymer microsphere microtechnology for sustained drug release; MidaSolve, an oligosaccharide nanotechnology enabling the solubilization and direct, localized liquid administration of drugs into tumors; and MidaCore, a gold nanoparticle system engineered for targeted delivery of chemotherapeutic or immunotherapeutic agents to disease sites. Founded in 2000, Midatech Pharma plc is headquartered in Cardiff, United Kingdom.

Market snapshot

Symbol
MTP
Price
$0.29
Day change
-18.50%
Market cap
$1.7M
P/E ratio
-0.03x
52-week range
0.19-20.8
Sector
Healthcare
Industry
Biotechnology

Recent news

  • Italy's banking shake-up: all the M&A deals since 2025

    Intesa Sanpaolo's takeover bid on smaller peer Monte dei Paschi di Siena would be the latest and biggest transformative deal for Italian banks. Here is a rundown of completed and attempted transactions that have shaken up the sector ​since the start of 2025.

Peer companies

  • Cutera, Inc. (CUTR)
  • Fresh2 Group Limited (FRES)
  • Novan, Inc. (NOVN)
  • Notable Labs, Ltd. (NTBL)
  • OncoSec Medical Incorporated (ONCSQ)
  • Oncternal Therapeutics, Inc. (ONCT)
  • PolarityTE, Inc. (PTE)
  • Palatin Technologies, Inc. (PTN)

Recent insider activity

  • Kiley Quinn Thomas — P-Purchase (1000 shares) on 2011-05-10
  • ZIMMERMAN GIFFORD R — trade (0 shares) on 2010-10-06
  • TOTH TERENCE J — trade (0 shares) on 2010-10-06
  • SCHNEIDER WILLIAM J — trade (0 shares) on 2010-10-06
  • MARTIN LARRY W — trade (0 shares) on 2010-10-06

Open Midatech Pharma plc (MTP) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.